|
Type | Culture medium | Working volume (mL) | MSC source/culture conditions | Time in culture (days) | Fold increase | Final cell number | Reference |
|
10-layer HYPER flasks (Corning) | α-MEM + 15% AB human serum | 560 | UCM MSC | 11 | 13 | 45 × 106 cells | [39] |
Roller bottles (Greiner) | α-MEM + 15% AB human serum | 200 | UCM MSC | 6 | 7.0 | 29 × 106 cells | [39] |
3 L stirred tank bioreactor (EMD Millipore, Mobius) | DMEM + 10% FBS | 2000 | BM and AT MSC on collagen-coated microcarriers | 5 | 5.2 | n.r. | [49] |
1 L bioreactor (Sartorius Biostat B-DCU) | DMEM + 10% FBS | 1000 | BM MSC cultivated on Cytodex-3 microcarrier | 8 | 12 | 600 × 106 cells | [50] |
3 L stirred tank bioreactor (Merck-Millipore, Mobius™ CellReady 3L) | DMEM + 10% FBS | 2400 | BM MSC cultured on collagen-coated SoloHill microcarriers | 12 | 62 | 270 × 106 cells/L | [51] |
5 L stirred tank bioreactor (Sartorius, Biostat B Plus) | DMEM + 10% FBS | 2500 | BM MSC cultivated on Plastic P-102L microcarrier | 12 | >6 | 420 × 106 cells | [52] |
1.3 L stirred tank bioreactor (New Brunswick, Bioflo) | StemPro® MSC SFM XenoFree | 800 | BM and AT MSC cultivated on nonporous plastic microcarrier | 7 | n.r. | 110 × 106 cells for BM MSC and 45 × 106 cells for AT MSC | [53] |
2 L stirred tank bioreactor (UniVessel SU, Sartorius) | Serum-reduced (5%) medium | 2000 | AT MSC cultivated on Pronectin F microcarrier | 7 | 27 | 540 × 106 cells | [54] |
2 L stirred tank bioreactor (Biostat B-DCU, Sartorius) | α-MEM + 10% FBS | 800 | Fetal BM MSC cultivated on Cytodex-3 | 7 | 16 | 0.46 × 105 cells/cm2 | [55] |
2.5 L stirred tank bioreactor (New Brunswich, Celligen 310) | StemPro MSC SFM XenoFree | 800 | UCM MSC cultivated in Cultispher-S microcarrier | 5 | 5.3 | 110 × 106 cells | [56] |
2.5 L stirred tank bioreactor (New Brunswich, Celligen 310) | α-MEM + 15% AB human serum | 800 | UCM MSC cultivated on Plastic P-102L microcarrier | 7 | 8.9 | 79 × 106 cells | [39] |
2 L stirred tank bioreactor (Sartorius, UniVessel® SU bioreactor) | Mesencult™-XF | 1000 | BM and AT MSC cultivated on Synthemax® II microcarrier | 7 | 14 for BM MSC and 16 for AT MSC | 680 × 106 cells for BM MSC and 820 × 106 cells for AT MSC | [57] |
Hollow fiber (Quantum, Terumo BCT) | DMEM + 10% Human Platelet Lysate | n.r. | BM MSC | 13 | 10–20 | 2–58 × 106 cells | [58] |
Hollow fiber (Quantum, Terumo BCT) | DMEM + 10% FBS | n.r. | BM MSC | 7 | 5.5–14 | 110–276 × 106 cells | [59] |
Hollow fiber (Quantum, Terumo BCT) | α-MEM + 10% FBS | n.r. | AT MSC | 17 | 4.7 | 99 × 106 cells | [60] |
Hollow fiber (Quantum, Terumo BCT) | DMEM + 10% FBS | n.r. | PD MSC | 8 | 16–22 | 316–444 × 106 cells | [61] |
Rocking bioreactor (GE Healthcare) | LGDMEM + 20% FBS | 2000 | Pl MSC cultivated on Cytodex-3 and Cultispher-S microcarrier | 7 | 10 for Cytodex-3; 15 for Cultispher-S | n.r. | [62] |
Fixed-bed bioreactor (New Brunswich) | α-MEM + 10% FBS | 500 | UCM MSC in a Fibrastage® bioreactor with FibraCel disks | 7 | 7 | 420 × 106 cells | [63] |
Fixed-bed bioreactor (New Brunswich, Celligen 310) | α-MEM + 10% FBS | 2500 | BM MSC | 9 | 9.2 | 10–92 × 106 cells | [64] |
|